RE: Trinity Delta Avacta Update out10 May 2023 10:39
Another day, another pile of FUD spamming from tweedledumb and tweedledumber. As noted by a few, raising cash isn’t an issue. They’re a biotech, it’s the business model until they commercialise something. The something is looking like AVA6k and it’s a market worth billions. A bit of dilution on the way is expected.
As for the note, I also thought the text highlighted by SB was interesting. They’ll have reached that conclusion for a reason. Otherwise, as Rah has said, maintaining the same CoS in the face of excellent progress is a nonsense. Still, unravel that 10% and you’ll get a valuation on the way to a tenner with 3996 queued up closely behind and not accounted for. Value will out, the market is thick as mince.